Nilotinib 150mg - Dosage Form: Hard Gelatin Capsule

4

3

1 Box/Boxes

1 Pack/Packs

100 Pack/Packs

Chronic Myeloid Leukemia (CML) - Newly diagnosed

Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Nilotinib (150mg)

Nilotinib

NILOTHERAPY 150 is a targeted anticancer medication containing Nilotinib (150mg), primarily used in the treatment of certain types of blood cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking abnormal proteins responsible for cancer cell growth. This medicine is widely prescribed for patients diagnosed with chronic myeloid leukemia (CML), especially those who are newly diagnosed or resistant to other therapies.NILOTHERAPY 150 is formulated to provide effective disease control while improving patient outcomes. It plays a crucial role in modern oncology by offering a more targeted and precise approach compared to conventional chemotherapy.UsesNILOTHERAPY 150 (Nilotinib 150mg) is primarily indicated for:Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)Management of newly diagnosed patients in the chronic phaseTreatment of patients who are resistant or intolerant to prior therapies like imatinibLong-term control of leukemia progressionThis medication is prescribed under strict medical supervision and is an essential part of personalized cancer therapy.BenefitsNILOTHERAPY 150 offers several clinically proven benefits:Targeted Action: Specifically inhibits cancer-causing proteins, reducing damage to healthy cellsEffective Disease Control: Helps in slowing or stopping the progression of CMLImproved Survival Rates: Enhances long-term survival in patients when taken regularlyReduced Resistance: Effective in patients who do not respond well to first-line treatmentsBetter Quality of Life: Minimizes symptoms such as fatigue, weakness, and infectionsIts precision-based mechanism makes it a preferred choice in modern hematology treatments.DosageThe dosage of NILOTHERAPY 150 should always be determined by a qualified healthcare professional based on the patient s condition and response to treatment.Typically taken twice daily on an empty stomachCapsules should be swallowed whole with waterAvoid food intake at least 2 hours before and 1 hour after taking the doseDo not crush or open the capsuleImportant Note: Patients must strictly follow the prescribed dosage schedule and should not skip or double doses without medical advice.Side EffectsLike all medications, NILOTHERAPY 150 may cause some side effects. Most are manageable and may reduce over time.Common Side Effects:Nausea and vomitingHeadacheFatigueRash or itchingConstipation or diarrheaSerious Side Effects (seek immediate medical attention):Irregular heartbeatSevere abdominal painLiver dysfunction (yellowing of skin or eyes)Low blood cell countsPancreatitisRegular monitoring through blood tests and medical check-ups is essential to ensure safety during treatment.Precautions and WarningBefore starting NILOTHERAPY 150, patients should consider the following precautions:Inform your doctor about any history of heart disease, liver problems, or pancreatitisRegular ECG and blood tests are recommended to monitor heart rhythm and liver functionAvoid grapefruit or grapefruit juice as it may interfere with the drug s metabolismNot recommended during pregnancy or breastfeeding without medical consultationUse effective contraception during treatmentInform your doctor about all other medications to avoid potential drug interactionsPatients should remain under continuous medical supervision while using this medication.ConclusionNILOTHERAPY 150 (Nilotinib 150mg) is a highly effective targeted therapy for managing chronic myeloid leukemia. With its precise mechanism of action, it helps control disease progression, improve survival rates, and enhance the quality of life for patients. However, due to its potent nature, it must be used strictly under medical guidance with regular monitoring.For patients seeking advanced and reliable cancer treatment options, NILOTHERAPY 150 stands as a trusted and clinically proven solution in modern oncology care.

Nilotinib

Nilotinib

150 mg

As Directed by the Physician

200 Mg

Store at 25 C (77 F); excursions permitted to 15 30 C

Store below 30AdegC

Store below 30 DegreeC

Others, Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Cash in Advance (CID)

Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Eastern Europe, North America, South America, Africa, Central America, Western Europe, Middle East, Asia, Australia